SCHEMBL7048480

SCHEMBL7048480

CC(=O)Oc1cc(C(=O)Cc2ccccc2)cc([N+](=O)[O-])c1OC(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 2/20 0.40
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.39
MAOA P21397 1/20 0.39
SRD5A2 P31213 1/20 0.39
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046245 0.89 NPC1 (0.45) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL7049743 0.84 BCL9 (0.41) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL7371498 0.84 VCAM1 (0.51) TOP1MEN1KMT2ATDP1MAPT
SCHEMBL9253473 0.83 LMNA (0.51) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL27672697 0.81 NPC1 (0.64) TOP1NPC1RAB9AMEN1KMT2A
SCHEMBL7044202 0.81 CA12 (0.38) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL7363637 0.81 TPMT (0.56) TOP1RAB9AMAPTALDH1A1LMNA
SCHEMBL7046037 0.79 NPC1 (0.43) NPC1RAB9AMEN1KMT2ATDP1
SCHEMBL7436807 0.78 TPMT (0.43) TOP1RAB9AMEN1KMT2ATDP1
SCHEMBL7048078 0.78 TTR (0.52) NPC1RAB9AMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed